Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cell-free DNA Methylation for the Diagnosis and Monitoring of Epithelial Ovarian Cancer: The Training and Validation Sets in China

NCT04651946 is registered in ClinicalTrials.gov with Lei Li as lead sponsor.

NCT NCT04651946
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04651946 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cell-free DNA Methylation for the Diagnosis and Monitoring of Epithelial Ovarian Cancer: The Training and Validation Sets in China
Lead sponsor
Lei Li
Phase
Phase 2
Overall status
Unknown status
Start date
November 26, 2020
Completion date
November 26, 2022
Enrollment
400 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign ovarian tumor, cell-free dna, dna methylation, epithelial ovarian cancer, liquid biopsy, training set, validation set